Established Leaders Cohort 2026-27

Anita Siu is a Clinical Professor, the Vice Chair for Teaching and Learning, and Director of Faculty Development and Mentoring at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey. She is a Pediatric Pharmacy Clinical Coordinator and practices at the K. Hovnanian Children’s Hospital and Jersey Shore University Medical Center, a part of the Hackensack Meridian Health System (HMH), and serves as a liaison between the Department of Pharmacy and Pediatrics. Currently, she leads the HMH Pediatric Specialty Pharmacotherapy Council network initiatives. Dr. Siu earned her Bachelor’s and Doctorate in Pharmacy from Philadelphia College of Pharmacy and completed two years of Pharmacy residency training, General Pediatrics and Neonatal/Pediatric Critical Care also at her alma mater. She was also the first pharmacist inducted as a member to the Stuart D. Cook, M.D. Master Educators’ Guild at Rutgers University and completed her term as the Secretary/Treasurer for the Rutgers Health Faculty Council. She is also a trained facilitator with the Center for the Improvement of Mentored Experiences in Research (CIMER) where she leads workshops and training programs for mentors and mentees across career stages at the School of Pharmacy and Rutgers Health. Dr. Siu has also served two terms as Chair of the Specialty Council for Pediatric Pharmacy for the Board of Pharmacy Specialties (BPS), the board certification for pediatric pharmacists. In 2021, Dr. Siu was appointed and began her service to the Board of Directors for BPS is currently Chair. In 2023, Dr. Siu was elected to the American Academy of Pediatrics Section of Clinical Pharmacology and Therapeutics (SOCPT) Executive Committee as the Pediatric Pharmacy Association liaison. She recently received the Presidential Citation Award from the Pediatric Pharmacy Association due to her service with the American Academy of Pediatrics.

Carol Lutz, PhD is an Associate Professor in the Department of Microbiology, Biochemistry and Molecular Genetics at Rutgers Health-New Jersey Medical School. She is also an Associate Dean for Student Affairs in the Rutgers School of Graduate Studies. She teaches medical, dental, and graduate students, runs an extramurally funded research lab studying gene expression regulation in lung cancer, and works with more than 600 graduate students in administrative, academic, wellness and student affairs functions. Carol holds a BS with Highest Honors from the University of North Carolina-Chapel Hill and a PhD from Duke University.

Lindsay Lawer Shea, DrPH, MS is the director of the Rutgers Center for State Health Policy. Dr. Shea also holds a faculty appointment at the Rutgers Robert Wood Johnson Medical School Department of Psychiatry. She is experienced in public health, health services, and disability policy research, with special expertise in the use of large administrative datasets, including national Medicaid claims, to understand population-level trends among individuals with intellectual and developmental disabilities (IDD). Dr. Shea focuses much of her work on improving health outcomes and service systems for autistic adolescents, adults, and older adults, with an emphasis on service access, addressing health disparities, and policy-driven system reform. Ongoing projects include the Autism Transition Research Project (ATRP), which examines transition outcomes for youth entering adulthood, and Advancing the System of Care for Autistic Older Adults, which seeks to improve services for older autistic individuals. Her research portfolio includes several major NIH-supported projects, including National Institute of Child Health and Human Development (NICHD)-funded research programs focused on aging, maternal health outcomes, and disparities in health outcomes among Medicaid-enrolled individuals with autism. Dr. Shea has been recognized for her work by organizations including the School District of Philadelphia, where she received the Denny O’Brien Excellence in Community Advocacy Award (2016). Prior to joining Rutgers, she served as the director of the Policy and Analytics Center at the A.J. Drexel Autism Institute and an Associate Professor and interim Department Chair in the Health Management and Policy Department at the Dornsife School of Public Health at Drexel University. She earned her Doctor of Public Health in Health Policy and Social Justice from the Dornsife School of Public Health at Drexel University and holds a Master of Science in Social Policy from the University of Pennsylvania.

Nancy R. Kirsch, PT, DPT, PhD, FAPTA, is a professor of physical therapy and Chairperson of the Department of Rehabilitation and Movement Sciences in the School of Health Professions. She currently serves on the Board of Physical Therapy Examiners in New Jersey. She previously served two terms as President of the Federation of State Boards of Physical Therapy (FSBPT), and also previously served as President of the New Jersey Chapter of the American Physical Therapy Association APTA. She owned a physical therapy private practice prior to entering academia full-time. She serves on the faculty of PROBE for ethics remediation. She received her Bachelor’s degree from Temple University, her master’s from Montclair State, her clinical doctorate in physical therapy from Massachusetts General, and her PhD from UMDNJ (Rutgers). She completed the Kennedy Institute for Biomedical Ethics at Georgetown University and has a certificate in Health Care Administration from Seton Hall University. Her research interests are in professional development and return-to-practice for practitioners with ethical concerns.

Sophia Chen, DO, MPH is an Associate Professor of Pediatrics and the Interim Associate Dean of Graduate Medical Education at Rutgers New Jersey Medical School, where she previously served as the Associate Dean for Preclerkship Education. In her current leadership role, she oversees strategic development, regulatory compliance, and physician wellness across all residency and fellowship programs. Driven by a passion for educational innovation, she has a proven track record of spearheading major curricular transformations. Dedicated to cultivating the next generation of clinicians, she remains focused on implementing institutional best practices to elevate graduate medical training. Sophia earned a bachelor’s degree in biology from Johns Hopkins University, a Doctor of Osteopathic Medicine from the Chicago College of Osteopathic Medicine, and a Master of Public Health in Maternal and Child Health from the Tulane University School of Public Health and Tropical Medicine.

Vin Lo Re, MD, MSCE, FIDSA, FISPE, is a tenured Professor of Medicine (RWJMS) and Epidemiology (SPH), board-certified infectious diseases physician, and physician-scientist with a focus on clinical epidemiology and pharmacoepidemiology of infectious and liver diseases. Vin serves as director of the Rutgers Center for Pharmacoepidemiology and Treatment Science, which generates actionable evidence on the need, use, safety, and effectiveness of interventions and medical products, particularly drugs, biologics, vaccines, medical devices. Vin’s research has focused on the utilization, effectiveness, and safety of drugs in large populations, particularly among people living with HIV infection, viral hepatitis, and other liver diseases. His team pioneered the use of electronic healthcare data for the study of liver diseases and was the first to develop computable phenotypes for many liver-related conditions, such as decompensated cirrhosis, hepatocellular carcinoma, cholangiocarcinoma, hepatic steatosis, severe acute liver injury, and acute liver failure, within electronic healthcare data. The application of these methods has led to the conduct of important pharmacoepidemiologic studies. His research has been supported by a variety of funding agencies, including the National Institutes of Health, Food and Drug Administration, Agency for Healthcare Research and Quality, and Department of Veterans Affairs. He maintains a clinical practice devoted to the care of patients with chronic viral hepatitis. He has held various leadership positions in the American College of Rheumatology, Childhood Arthritis and Rheumatology Research Alliance, and International Society for Pharmacoepidemiology. He also serves as a consultant to the U.S. Food and Drug Administration Drug Safety and Risk Management Advisory Committee. He has been an active member of the International Society for Pharmacoepidemiology, serving on the Board of Directors from 2015-2018, Scientific Program Chair for the Society’s 35th annual meeting in Philadelphia in August 2019, and President from 2021-2022. He has also been Regional Editor for the Americas of the Society’s journal, Pharmacoepidemiology and Drug Safety, since 2018. He has chaired the US FDA’s Drug Safety and Risk Management Advisory Committee since 2022. He also served as Co-Chair of the American Association for the Study of Liver Diseases/Infectious Diseases Society of America Hepatitis C Guidance Panel from 2022-2025 Vin earned a bachelor’s degree in Chemistry from Georgetown University, a medical degree from the University of Pennsylvania School of Medicine, and a Master of Science in Clinical Epidemiology from the University of Pennsylvania.